Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Multi-center Study of Magnetic Resonance Imaging (MRI) With 0.1 mmol/kg Body Weight (BW) Gadavist (1.0 M) to Assess Pharmacokinetics, Safety and Tolerability in Children.

NCT00468819 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00468819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00468819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Multi-center Study of Magnetic Resonance Imaging (MRI) With 0.1 mmol/kg Body Weight (BW) Gadavist (1.0 M) to Assess Pharmacokinetics, Safety and Tolerability in Children.
Lead sponsor
Bayer
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2007
Completion date
April 30, 2008
Enrollment
140 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

magnetic resonance imaging